VIVO - Meridian Bioscience, Inc.
| Previous Close | 14.55 |
| Open | 14.55 |
| Bid | 14.35 x 500 |
| Ask | 14.40 x 500 |
| Day's Range | 14.35 - 14.70 |
| 52 Week Range | 13.23 - 16.45 |
| Volume | 72,410 |
| Avg. Volume | 307,206 |
| Market Cap | 607.116M |
| Beta | 0.69 |
| PE Ratio (TTM) | 28.14 |
| EPS (TTM) | 0.51 |
| Earnings Date | Nov 8, 2017 - Nov 13, 2017 |
| Forward Dividend & Yield | 0.50 (3.47%) |
| Ex-Dividend Date | 2018-02-02 |
| 1y Target Est | 15.00 |
- GlobeNewswire•18 days ago
Research Report Identifies Meridian Bioscience, Baozun, MAG Silver, Heritage-Crystal Clean, Och-Ziff Capital Management Group, and EP Energy with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
NEW YORK, April 05, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
- GlobeNewswire•19 days ago
Meridian Bioscience, Inc. Expects to Report Second Quarter Fiscal Year 2018 Operating Results on Thursday, April 26, 2018
CINCINNATI, April 04, 2018-- Meridian Bioscience, Inc., a leading diagnostic and life science component company, expects to release its second quarter fiscal 2018 operating results before the NASDAQ market ...
- GlobeNewswire•last month
Meridian Bioscience Realigns Organizational Structure
New Structure Consists of two Business Units, Diagnostics and Life Science, Supported by a Global Corporate Team Realignment Aimed at Building a Stronger, More Sustainable Organization; Paving the Way ...
- ACCESSWIRE•2 months ago
Lawsuit for Investors in Meridian Bioscience, Inc. (NASDAQ: VIVO) Shares Announced by Shareholders Foundation
SAN DIEGO, CA / ACCESSWIRE / February 12, 2018 / The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain purchasers of NASDAQ: VIVO shares against Meridian Bioscience, Inc. over ...
- Simply Wall St.•2 months ago
Top NasdaqGS Healthcare Dividend Paying Companies
The healthcare sector has a higher prevalence of companies with sustainable competitive advantages compared to other sectors which implies it may continue generating robust excess returns. When the economy isRead More...
- GlobeNewswire•2 months ago
New Research: Key Drivers of Growth for Tallgrass Energy GP, LP, Lithia Motors, Akcea Therapeutics, Meridian Bioscience, Myomo, and Liberty Media — Factors of Influence, Major Initiatives and Sustained Production
NEW YORK, Feb. 06, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Tallgrass ...
- ACCESSWIRE•3 months ago
Free Post Earnings Research Report: Meridian’s Quarterly Revenue Grew 12%; Non-GAAP Earnings Advanced 4%
LONDON, UK / ACCESSWIRE / February 05, 2018 / Active-Investors.com has just released a free earnings report on Meridian Bioscience, Inc. (NASDAQ: VIVO ) (“Meridian”). If you want access to this report ...
- Associated Press•3 months ago
Meridian Bioscience beats 1Q profit forecasts
On a per-share basis, the Cincinnati-based company said it had net income of 15 cents. The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ...
- GlobeNewswire•3 months ago
Meridian Bioscience Reports First Quarter 2018 Operating Results, Declares Regular First Quarter Cash Dividend, and Reaffirms Fiscal 2018 Guidance
CINCINNATI, Jan. 25, 2018-- Meridian Bioscience, Inc. today:. reported first quarter net revenues of $52.3 million, an increase of 12% from the same period of the prior fiscal year; reported first quarter ...
- Business Wire•3 months ago
MERIDIAN BIOSCIENCE INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Meridian Bioscience, Inc. – VIVO
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC , announces that KSF has commenced an investigation into Meridian Bioscience, Inc.
- ACCESSWIRE•3 months ago
FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Meridian Bioscience, Inc. (VIVO) & Lead Plaintiff Deadline - January 16, 2018
NEW YORK, NY / ACCESSWIRE / January 16, 2018 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Meridian Bioscience, Inc. ("Meridian Bioscience") ...
- ACCESSWIRE•3 months ago
The Klein Law Firm Reminds Investors of Commencement of a Class Action on Behalf of Meridian Bioscience, Inc. Shareholders and a Lead Plaintiff Deadline of January 16, 2018 (VIVO)
NEW YORK, NY / ACCESSWIRE / January 15, 2018 / The Klein Law Firm reminds shareholders that a class action complaint has been filed on behalf of shareholders of Meridian Bioscience, Inc. (NASDAQ: VIVO) ...
- PR Newswire•3 months ago
MERIDIAN BIOSCIENCE INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Meridian Bioscience, Inc. - VIVO
NEW ORLEANS , Jan. 12, 2018 /PRNewswire/ -- Former Attorney General of Louisiana , Charles C. Foti, Jr., Esq. , a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF ...
- Business Wire•3 months ago
Glancy Prongay & Murray Reminds Investors of the January 16, 2018 Deadline in the Class Action Lawsuit Against Meridian Bioscience, Inc. (VIVO)
Glancy Prongay & Murray LLP reminds investors of the January 16, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Meridian Bioscience, Inc.
- ACCESSWIRE•3 months ago
UPCOMING DEADLINE: The Klein Law Firm Reminds Investors of a Class Action on Behalf of Meridian Bioscience, Inc. Shareholders and a Lead Plaintiff Deadline of January 16, 2018 (VIVO)
NEW YORK, NY / ACCESSWIRE / January 12, 2018 / The Klein Law Firm reminds shareholders that a class action complaint has been filed on behalf of shareholders of Meridian Bioscience, Inc. (NASDAQ: VIVO) ...
- ACCESSWIRE•3 months ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Meridian Bioscience, Inc. - VIVO
NEW YORK, NY / ACCESSWIRE / January 12, 2018 / Pomerantz LLP is investigating claims on behalf of investors of Meridian Bioscience, Inc. ("Meridian" or the "Company") (NASDAQ: VIVO). ...
- American City Business Journals•3 months ago
Greater Cincinnati firm faces lawsuits linked to FDA warning, stock dip
The value of the stock shifted after a division of Greater Cincinnati’s 25th-largest public company was cited for alleged violations by a federal agency. The FDA noted that it had issued an advisory to the public in May that Magellan’s LeadCare test systems performed on blood drawn from a vein might provide low results that were erroneous.
- ACCESSWIRE•3 months ago
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed a Complaint to Recover Losses Suffered by Investors in Meridian Bioscience, Inc. and Set a Lead Plaintiff Deadline of January 16, 2018 -- VIVO
NEW YORK, NY / ACCESSWIRE / January 11, 2018 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired shares of Meridian Bioscience, ...
- Business Wire•3 months ago
VIVO INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Meridian Bioscience, Inc. Investors and Encourages Investors to Contact the Firm
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors that purchased Meridian Bioscience, Inc. securities between March 25, 2016 and July 13, 2017, inclusive Meridian Bioscience investors have until January 16, 2018 to file a lead plaintiff motion.
- ACCESSWIRE•3 months ago
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed a Complaint to Recover Losses Suffered by Investors in Meridian Bioscience, Inc. and Set a Lead Plaintiff Deadline of January 16, 2018 -- VIVO
NEW YORK, NY / ACCESSWIRE / January 9, 2018 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired shares of Meridian Bioscience, ...
- ACCESSWIRE•3 months ago
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Meridian Bioscience, Inc. (VIVO) & Lead Plaintiff Deadline - January 16, 2018
NEW YORK, NY / ACCESSWIRE / January 9, 2018 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Meridian Bioscience, Inc. ("Meridian Bioscience") ...
- Business Wire•3 months ago
Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Meridian Bioscience, Inc. Investors and Encourages Investors to Contact the Firm (VIVO)
Glancy Prongay & Murray LLP announces that a class action lawsuit has been filed on behalf of investors that purchased Meridian Bioscience, Inc. securities between March 25, 2016 and July 13, 2017, inclusive .
